Simple risk models to predict cardiovascular death in patients with stable coronary artery disease.


Journal

European heart journal. Quality of care & clinical outcomes
ISSN: 2058-1742
Titre abrégé: Eur Heart J Qual Care Clin Outcomes
Pays: England
ID NLM: 101677796

Informations de publication

Date de publication:
03 05 2021
Historique:
received: 13 11 2019
revised: 20 12 2019
accepted: 06 01 2020
pubmed: 11 1 2020
medline: 15 12 2021
entrez: 11 1 2020
Statut: ppublish

Résumé

Risk estimation is important to motivate patients to adhere to treatment and to identify those in whom additional treatments may be warranted and expensive treatments might be most cost effective. Our aim was to develop a simple risk model based on readily available risk factors for patients with stable coronary artery disease (CAD). Models were developed in the CLARIFY registry of patients with stable CAD, first incorporating only simple clinical variables and then with the inclusion of assessments of left ventricular function, estimated glomerular filtration rate, and haemoglobin levels. The outcome of cardiovascular death over ∼5 years was analysed using a Cox proportional hazards model. Calibration of the models was assessed in an external study, the CORONOR registry of patients with stable coronary disease. We provide formulae for calculation of the risk score and simple integer points-based versions of the scores with associated look-up risk tables. Only the models based on simple clinical variables provided both good c-statistics (0.74 in CLARIFY and 0.80 or over in CORONOR), with no lack of calibration in the external dataset. Our preferred model based on 10 readily available variables [age, diabetes, smoking, heart failure (HF) symptom status and histories of atrial fibrillation or flutter, myocardial infarction, peripheral arterial disease, stroke, percutaneous coronary intervention, and hospitalization for HF] had good discriminatory power and fitted well in an external dataset. The CLARIFY registry is registered in the ISRCTN registry of clinical trials (ISRCTN43070564).

Identifiants

pubmed: 31922541
pii: 5699910
doi: 10.1093/ehjqcco/qcz070
pmc: PMC8092988
doi:

Banques de données

ISRCTN
['ISRCTN43070564']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-294

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Arch Intern Med. 2007 Jan 8;167(1):68-73
pubmed: 17210880
Lancet. 2018 May 12;391(10133):1897-1907
pubmed: 29735391
Am J Cardiol. 2014 Apr 1;113(7):1142-5
pubmed: 24507170
Lancet. 2005 Jan 1-7;365(9453):82-93
pubmed: 15639683
BMJ. 2006 Feb 4;332(7536):262-7
pubmed: 16415069
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
BMJ. 2009 Mar 31;338:b604
pubmed: 19336487
Stat Methods Med Res. 2016 Aug;25(4):1692-706
pubmed: 23907781
J Am Coll Cardiol. 2001 Jul;38(1):56-63
pubmed: 11451296
Eur J Clin Invest. 2013 Feb;43(2):141-51
pubmed: 23278283
Clin Cardiol. 2017 Oct;40(10):797-806
pubmed: 28561986
J Am Heart Assoc. 2015 Jul 06;4(7):
pubmed: 26150476
Am J Cardiol. 2013 Jul 1;112(1):27-33
pubmed: 23558041
Circulation. 2012 Dec 18;126(25):3097-137
pubmed: 23166210
J Am Coll Cardiol. 2017 Aug 15;70(7):813-826
pubmed: 28797349
Lifetime Data Anal. 1998;4(2):109-20
pubmed: 9658770
Eur Heart J. 2014 Apr;35(13):844-52
pubmed: 24353280
Circulation. 2017 Nov 14;136(20):1908-1919
pubmed: 28844989
Circulation. 2016 Jul 26;134(4):304-13
pubmed: 27440003
Circulation. 2014 Mar 25;129(12):1286-94
pubmed: 24515993
Coron Artery Dis. 2017 Dec;28(8):636-641
pubmed: 28914638
Eur Heart J. 2013 Oct;34(38):2949-3003
pubmed: 23996286
Am J Med. 2012 Jul;125(7):695-703.e1
pubmed: 22727237
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Heart. 2016 Jun 1;102(11):869-75
pubmed: 26928409
JAMA. 2006 Jan 11;295(2):180-9
pubmed: 16403930
BMJ. 2005 Oct 15;331(7521):869
pubmed: 16210253

Auteurs

Ian Ford (I)

Robertson Centre for Biostatistics, University of Glasgow, Level 11, Boyd Orr Building, Glasgow G12 8QQ, UK.

Michele Robertson (M)

Robertson Centre for Biostatistics, University of Glasgow, Level 11, Boyd Orr Building, Glasgow G12 8QQ, UK.

Nicola Greenlaw (N)

Robertson Centre for Biostatistics, University of Glasgow, Level 11, Boyd Orr Building, Glasgow G12 8QQ, UK.

Christophe Bauters (C)

Cardiology Department, Institut Coeur Poumon, CHU, Université de Lille, Bd du Professeur Jules Leclercq, 59000 Lille, France.

Gilles Lemesle (G)

Cardiology Department, Institut Coeur Poumon, CHU, Université de Lille, Bd du Professeur Jules Leclercq, 59000 Lille, France.

Emmanuel Sorbets (E)

National Heart and Lung Institute, Imperial College, Dovehouse Street London SW3 6LY, UK.
Royal Brompton Hospital, Sydney St, London SW3 6NP, UK.
FACT (French Alliance for Cardiovascular Trials), Université de Paris, and AP-HP, Hopital Bichat, INSERM U1148, 46 rue Henri Huchard 75018 Paris, France.
Université de Paris 13, Sorbonne Paris Cité, AP-HP, Hôpital Avicenne, Bobigny, France.
Université de Paris, AP-HP, Hôtel-Dieu, Centre de Diagnostic et de thérapeutique, 1 rue de la Cité, 75004 Paris, France.

Roberto Ferrari (R)

Centro Cardiologico Universitario di Ferrara, University of Ferrara, Maria Cecilia Hospital, GVM Care & Research, Via Corriera, 1 48010 Cotignola, Ravenna, Italy.

Jean-Claude Tardif (JC)

Montreal Heart Institute, 5000 Belanger Street, Montreal, H1T1C8, Université de Montréal, Canada.

Michal Tendera (M)

Department of Cardiology and Structural Heart Disease, Medical School in Katowice, Medical University of Silesia, Ziolowa Str. 45/47, 40-635 Katowice, Poland.

Kim Fox (K)

National Heart and Lung Institute, Imperial College, Dovehouse Street London SW3 6LY, UK.
Royal Brompton Hospital, Sydney St, London SW3 6NP, UK.

Philippe Gabriel Steg (PG)

National Heart and Lung Institute, Imperial College, Dovehouse Street London SW3 6LY, UK.
Royal Brompton Hospital, Sydney St, London SW3 6NP, UK.
FACT (French Alliance for Cardiovascular Trials), Université de Paris, and AP-HP, Hopital Bichat, INSERM U1148, 46 rue Henri Huchard 75018 Paris, France.
Université de Paris 13, Sorbonne Paris Cité, AP-HP, Hôpital Avicenne, Bobigny, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH